Oncocin [R15,19r; P10W], Onc264

General Information


DRACP ID  DRACP04325

Peptide Name   Oncocin [R15,19r; P10W], Onc264

Sequence  VDKPPYLPRWRPPRrIYNr

Sequence Length  19

UniProt ID  A0A2R7WNA0 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C103H151N29O21

Absent amino acids  ACEFGHMQST

Common amino acids  P

Mass  245273

Pl  10.64

Basic residues  4

Acidic residues  1

Hydrophobic residues  4

Net charge  3

Boman Index  -4974

Hydrophobicity  -123.16

Aliphatic Index  56.32

Half Life 
  /

Extinction Coefficient cystines  8480

Absorbance 280nm  471.11

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34902208

Title  Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18921

DRACP is developed by Dr.Zheng's team.